Holcim Ltd Unsponsored ADR (OTCMKTS:HCMLY – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $16.80.
HCMLY has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Holcim in a research note on Friday, July 3rd. Royal Bank Of Canada reissued a “sector perform” rating on shares of Holcim in a research note on Monday.
Check Out Our Latest Stock Analysis on Holcim
Holcim Price Performance
Shares of OTCMKTS:HCMLY traded down $0.05 during midday trading on Monday, hitting $16.07. 234,421 shares of the stock were exchanged, compared to its average volume of 156,891. Holcim has a 52-week low of $14.79 and a 52-week high of $21.23. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.09 and a quick ratio of 0.84. The business’s fifty day simple moving average is $16.58 and its two-hundred day simple moving average is $17.79.
Holcim Company Profile
Holcim Ltd. is a Switzerland-based global building materials and solutions company. Its products and services support residential, commercial and infrastructure construction, with operations spanning cement, aggregates, ready-mix concrete and related building solutions.
The company also provides value-added products such as roofing systems, insulation, facade solutions and other materials designed to improve the performance, durability and sustainability of buildings. Holcim serves customers including construction companies, contractors, developers, distributors and infrastructure operators.
Holcim traces its history to Switzerland and expanded significantly through international growth and acquisitions.
Featured Stories
- Five stocks we like better than Holcim
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Holcim Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Holcim and related companies with MarketBeat.com's FREE daily email newsletter.
